Fluidigm to expand sales staff over next two years
Fluidigm intends to significantly expand its sales staff, particularly in North America, over the next two years, President and CEO Gajus Worthington told GenomeWeb Daily News this week.
Fluidigm Corp., which makes systems to control fluids for life science research, plans an initial public offering of common stock, according to a Securities and Exchange Commission filing on Monday.